In parallel, we over-expressed EYA4 in the ER+/PR+ breast cancer cell line, MCF-7 (Fig. S1G), which expresses low or no detectable endogenous EYA4 ([28], Fig. S1B-C and Cancer Cell Line Encyclopedia, https://sites.broadinstitute.org/ccle). This evidence concerns the gene ESR1 and breast carcinoma.